NasdaqCM - Delayed Quote • USD
Virpax Pharmaceuticals, Inc. (VRPX)
At close: April 25 at 4:00 PM EDT
Insider Roster
Insider roster data is derived solely from the last 24 months of Form 3 & Form 4 SEC filings.
| Individual or Entity | Most Recent Transaction | Date | Shares Owned as of Transaction Date |
|---|---|---|---|
| FLOYD ERIC Director | Purchase | May 18, 2022 | 8,018 |
| JACOB GARY S Director | Purchase | Feb 17, 2021 | 3,500 |
| JAMBULINGAM THANI Director | Purchase | Feb 17, 2021 | 100 |
| MACK ANTHONY P. Chief Executive Officer | Purchase | May 18, 2022 | 2,983,000 |
| SENDROW JERROLD B Director | Purchase | May 24, 2022 | 9,006 |
Related Tickers
RNXT RenovoRx, Inc.
1.2100
-1.63%
XBIO Xenetic Biosciences, Inc.
3.7759
-0.11%
CMMB Chemomab Therapeutics Ltd.
0.6590
-1.64%
NRBO NeuroBo Pharmaceuticals, Inc.
3.0600
-1.29%
SABS SAB Biotherapeutics, Inc.
4.0100
-9.89%
FNCH Finch Therapeutics Group, Inc.
2.2400
-2.18%
CYTO Altamira Therapeutics Ltd.
1.6000
+11.11%
QNRX Quoin Pharmaceuticals, Ltd.
0.6300
-1.95%
KPRX Kiora Pharmaceuticals, Inc.
0.4800
-5.10%
NRXPW NRx Pharmaceuticals, Inc.
0.1464
-8.50%